Regulation of membrane permeability by a two-component regulatory system in Pseudomonas aeruginosa

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 1, 2003, Pages 95-101

  Wang, Yanping ^a   Ha, Unhwan ^a   Zeng, Lin ^a   Jin, Shouguang ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; CARBENICILLIN; CIPROFLOXACIN; ERYTHROMYCIN; GENTAMICIN; NEOMYCIN; PROTEIN HISTIDINE KINASE; STREPTOMYCIN; TETRACYCLINE; TOBRAMYCIN;

ARTICLE; BACTERIAL MEMBRANE; BACTERIUM ISOLATE; GENE EXPRESSION; MEMBRANE PERMEABILITY; MULTIDRUG RESISTANCE; NONHUMAN; PLASMID; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; REGULATOR GENE; REGULATORY MECHANISM;

EID: 0037229793     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.1.95-101.2003     Document Type: Article

References (38)

1. Alonso, A., E. Campanario, and J. L. Martinez. 1999. Emergence of multidrug-resistant mutants is increased under antibiotic selective pressure in Pseudomonas aeruginosa. Microbiology 145(Pt 10):2857-2862.
2. Bodey, G. P., R. Bolivar, V. Fainstein, and L. Jadeja. 1983. Infections caused by Pseudomonas aeruginosa. Rev. Infect. Dis. 5:279-313.
3. Bryan, L. E. 1988. General mechanisms of resistance to antibiotics. J. Antimicrob. Chemother. 22(Suppl. A):1-15.
4. Bryan, L. E., K. O'Hara, and S. Wong. 1984. Lipopolysaccharide changes in impermeability-type aminoglycoside resistance in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 26:250-255.
5. Burns, J. L., J. M. Van Dalfsen, R. M. Shawar, K. L. Otto, R. L. Garber, J. M. Quan, A. B. Montgomery, G. M. Albers, B. W. Ramsey, and A. L. Smith. 1999. Effect of chronic intermittent administration of inhaled tobramycin on respiratory microbial flora in patients with cystic fibrosis, J. Infect. Dis. 179:1190-1196.
6. Gilligan, P. H. 1991. Microbiology of airway disease in patients with cystic fibrosis. Clin. Microbiol. Rev. 4:35-51.
7. Hanahan, D. 1983. Studies on transformation of Escherichia coli with plasmids. J. Mol. Biol. 166:557-580.
8. Holder, I. A. 1993. Pseudomonas aeruginosa virulence-associated factors and their role in burn wound infections, p. 235-245. In R. B. Fick, Jr. (ed.), Pseudomonas aeruginosa, the opportunist pathogenesis and disease. CRC Press, Inc., Boca Raton, Fla.
9. Karlowsky, J. A., S. A. Zelenitsky, and G. G. Zhanel. 1997. Aminoglycoside adaptive resistance. Pharmacotherapy 17:549-555.
10. LeClerc, J. E., and T. A. Cebula. 2000. Pseudomonas survival strategies in cystic fibrosis. Science 289:391-392.
11. Mao, W., M. S. Warren, A. Lee, A. Mistry, and O. Lomovskaya. 2001. MexXY-OprM efflux pump is required for antagonism of aminoglycosides by divalent cations in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 45:2001-2007.
12. Martinez, M. B., M. C. Flickinger, and G. L. Nelsestuen. 1996. Accurate kinetic modeling of alkaline phosphatase in the Escherichia coli periplasm: implications for enzyme properties and substrate diffusion. Biochemistry. 35:1179-1186.
13. Martinez, M. B., F. J. Schendel, M. C. Flickinger, and G. L. Nelsestuen. 1992. Kinetic properties of enzyme populations in vivo: alkaline phosphatase of the Escherichia coli periplasm. Biochemistry 31:11500-11509.
14. Masuda, N., E. Sakagawa, S. Ohya, N. Gotoh, H. Tsujimoto, and T. Nishino. 2000. Contribution of the MexX-MexY-OprM efflux system to intrinsic resistance in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 44:2242-2246.
15. Masuda, N., E. Sakagawa, S. Ohya, N. Gotoh, H. Tsujimoto, and T. Nishino. 2000. Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXY-OprM efflux pumps in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 44:3322-3327.
16. Miller, J. H. 1972. Experiments in molecular genetics. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
17. Moore, R. A., and R. E. Hancock. 1986. Involvement of outer membrane of Pseudomonas cepacia in aminoglycoside and polymyxin resistance. Antimicrob. Agents Chemother. 30:923-926.
18. Mouton, J. W., J. G. den Hollander, and A. M. Horrevorts. 1993. Emergence of antibiotic resistance amongst Pseudomonas aeruginosa isolates from patients with cystic fibrosis. J. Antimicrob. Chemother. 31:919-926.
19. National Committee for Clinical Laboratory Standards. 1997. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 4th ed. Approved standard M7-A4. National Committee for Clinical Laboratory Standards Wayne, Pa.
20. Nikaido, H. 1994. Prevention of drug access to bacterial targets: permeability barriers and active efflux. Science 264:382-388.
21. Nunn, D. N., and S. Lory. 1991. Product of the Pseudomonas aeruginosa gene pilD is a prepilin leader peptidase. Proc. Natl. Acad. Sci. USA 88:3281-3285.
22. Oliver, A., R. Canton, P. Campo, F. Baquero, and J. Blazquez. 2000. High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science 288:1251-1254.
23. Ouchane, S., and S. Kaplan. 1999. Topological analysis of the membranelocalized redox-responsive sensor kinase PpprB from Rhodobacter sphaeroides 2.4.1. J. Biol. Chem. 274:17290-17296.
24. Poole, K., and R. Srikumar. 2001. Multidrug efflux in Pseudomonas aeruginosa: components, mechanisms and clinical significance. Curr. Top. Med. Chem. 1:59-71.
25. Putman, M., H. W. van Veen, and W. N. Konings. 2000. Molecular properties of bacterial multidrug transporters. Microbiol. Mol. Biol. Rev. 64:672-693.
26. Rolinson, G. N. 1991. Evolution of beta-lactamase inhibitors. Rev. Infect. Dis. 13(Suppl. 9):S727-S732.
27. Saiman, L., F. Mehar, W. W. Niu, H. C. Neu, K. J. Shaw, G. Miller, and A. Prince. 1996. Antibiotic susceptibility of multiply resistant Pseudomonas aeruginosa isolated from patients with cystic fibrosis, including candidates for transplantation. Clin. Infect. Dis. 23:532-537.
28. Shawar, R. M., D. L. MacLeod, R. L. Garber, J. L. Burns, J. R. Stapp, C. R. Clausen, and S. K. Tanaka. 1999. Activities of tobramycin and six other antibiotics against Pseudomonas aeruginosa isolates from patients with cystic fibrosis. Antimicrob. Agents Chemother. 43:2877-2880.
29. Shearer, B. G., and N. J. Legakis. 1985. Pseudomonas aeruginosa: evidence for the involvement of lipopolysaccharide in determining outer membrane permeability to carbenicillin and gentamicin. J. Infect. Dis. 152:351-355.
30. Stover, C. K., X. Q. Pham, A. L. Erwin, S. D. Mizoguchi, P. Warrener, M. J. Hickey, F. S. Brinkman, W. O. Hufnagle, D. J. Kowalik, M. Lagrou, R. L. Garber, L. Goltry, E. Tolentino, S. Westbrock-Wadman, Y. Yuan, L. L. Brody, S. N. Coulter, K. R. Folger, A. Kas, K. Larbig, R. Lim, K. Smith, D. Spencer, G. K. Wong, Z. Wu, and I. T. Paulsen. 2000. Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature 406:959-964.
31. Tatterson, L. E., J. F. Poschet, A. Firoved, J. Skidmore, and V. Deretic. 2001. CFTR and Pseudomonas infections in cystic fibrosis. Front Biosci. 6:D890-D897.
32. Totten, P. A., J. C. Lara, and S. Lory. 1990. The rpoN gene product of Pseudomonas aeruginosa is required for expression of diverse genes, including the flagellin gene. J. Bacteriol. 172:389-396.
33. Totten, P. A., and S. Lory. 1990. Characterization of the type a flagellin gene from Pseudomonas aeruginosa PAK. J. Bacteriol. 172:7188-7199.
34. West, S. E., H. P. Schweizer, C. Dall, A. K. Sample, and L. J. RunyenJanecky. 1994. Construction of improved Escherichia-Pseudomonas shuttle vectors derived from pUC18/19 and sequence of the region required for their replication in Pseudomonas aeruginosa. Gene 148:81-86.
35. Westbrock-Wadman, S., D. R. Sherman, M. J. Hickey, S. N. Coulter, Y. Q. Zhu, P. Warrener, L. Y. Nguyen, R. M. Shawar, K. R. Folger, and C. K. Stover. 1999. Characterization of a Pseudomonas aeruginosa efflux pump contributing to aminoglycoside impermeability. Antimicrob. Agents Chemother. 43:2975-2983.
36. Whiteley, M., M. G. Bangera, R. E. Bumgarner, M. R. Parsek, G. M. Teitzel, S. Lory, and E. P. Greenberg. 2001. Gene expression in Pseudomonas aeruginosa biofilms. Nature 413:860-864.
37. Xiong, Y. Q., J. Caillon, M. F. Kergueris, H. Drugeon, D. Baron, G. Potel, and A. S. Bayer. 1997. Adaptive resistance of Pseudomonas aeruginosa induced by aminoglycosides and killing kinetics in a rabbit endocarditis model. Antimicrob. Agents Chemother. 41:823-826.
38. Zhulin, I. B., B. L. Taylor, and R. Dixon. 1997. PAS domain S-boxes in Archaea, Bacteria and sensors for oxygen and redox. Trends Biochem. Sci. 22:331-333.